Disease burden of post-infectious irritable bowel syndrome in The Netherlands

被引：51

作者：

Haagsma, J. A. ^{[1
,2
]}

Siersema, P. D. ^{[3
]}

De Wit, N. J. ^{[4
]}

Havelaar, A. H. ^{[5
]}

机构：

[1] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands

[2] Erasmus Univ, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands

[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[4] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[5] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands

来源：

EPIDEMIOLOGY AND INFECTION | 2010年 / 138卷 / 11期

关键词：

Campylobacter; foodborne infections; public health; salmonellosis; Shigella; QUALITY-OF-LIFE; BACTERIAL GASTROENTERITIS; GASTROINTESTINAL SYMPTOMS; INFECTION; COHORT; METAANALYSIS; PREVALENCE; OUTBREAK; DIARRHEA; RISK;

D O I：

10.1017/S0950268810000531

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Post-infectious irritable bowel syndrome (PI-IBS) has been established as a sequel of infectious intestinal disease (IID). The aim of this study was to estimate the burden of PI-IBS caused by the pathogens Campylobacter, Salmonella and Shigella, and to compare this with other outcomes associated with these pathogens. The attributable risk of PI-IBS due to bacterial pathogens was calculated and linked to national data on gastroenteritis incidence and measures for severity and duration of illness in order to estimate the burden of PI-IBS. One year post-infection, IBS developed in 9% of patients with bacterial IID. The burden of PI-IBS adds over 2300 disability adjusted life years to the total annual disease burden for the selected pathogens. PI-IBS is a frequent sequel of IID, resulting in a considerable disease burden compared to other outcomes. If this relationship is not considered, this will result in an underestimation of the disease burden of IID.

引用

页码：1650 / 1656

页数：7

共 39 条

[1]

[Anonymous], RISK ANAL QUANTATIVE

[2] Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients [J].

Bijkerk, C. J. ;

Muris, J. W. M. ;

Knottnerus, J. A. ;

Hoes, A. W. ;

de Wit, N. J. .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (11) :1176-1181

[3] A comparison of the EQ-5D and SF-6D across seven patient groups [J].

Brazier, J ;

Roberts, J ;

Tsuchiya, A ;

Busschbach, J .

HEALTH ECONOMICS, 2004, 13 (09) :873-884

[4]

Cressey P., 2007, Risk Ranking: Estimates of the burden of foodborne Disease for New Zealand

[5]

Crowell Michael D, 2004, Curr Opin Investig Drugs, V5, P55

[6] Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues [J].

Cuomo, Rosario ;

Savarese, Maria Flavia ;

Gargano, Rosalba .

DIGESTIVE DISEASES, 2007, 25 (03) :241-244

[7] Sensor, a population-based cohort study on gastroenteritis in the Netherlands:: Incidence and etiology [J].

de Wit, MAS ;

Koopmans, MPG ;

Kortbeek, LM ;

Wannet, WJB ;

Vinjé, J ;

van Leusden, F ;

Bartelds, AIM ;

van Duynhoven, YTHF .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (07) :666-674

[8] Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases [J].

Doorduyn, Y. ;

Van Pelt, W. ;

Siezen, C. L. E. ;

Van Der Horst, F. ;

Van Duynhoven, Y. T. H. P. ;

Hoebee, B. ;

Janssen, R. .

EPIDEMIOLOGY AND INFECTION, 2008, 136 (09) :1225-1234

[9] Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome [J].

Dunlop, SP ;

Coleman, NS ;

Blackshaw, E ;

Perkins, AC ;

Singh, G ;

Marsden, CA ;

Spiller, RC .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (04) :349-357

[10] Postinfectious irritable Bowel syndrome [J].

DuPont, Andrew W. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (04) :594-599

← 1 2 3 4 →